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Mongar  and  Schild  have  demonstrated that  the  anaphylactic release  of 
histamine from chopped  guinea pig  lung requires  calcium  and a  heat-labile 
factor, and can be inhibited by metabolic  inhibitors such as iodoacetate and 
cyanide  (1-3).  The  effectiveness  of these  and  other  non-specific  metabolic 
inhibitors in preventing the in ~itro anaphylactic reaction has been confirmed 
by other workers studying the release of histamine from chopped  guinea pig 
and rat tissue (4) and the degranulation of mast cells in the mesentery of the 
guinea pig (5) and rat (6, 7). 
Since the metabolic inhibitors used  by all  these workers  influence a  wide 
range of enzymes and can alter a variety of tissue  metabolic processes, they 
offer only limited insight into the type of enzymatic processes involved.  We 
therefore attempted to use inhibitors  which were more selective in action, and 
most of our studies were done with competitive rather than non-competitive 
inhibitors.  Many of the compounds studied were synthetic substxates and were 
selected in the hope that they would produce inhibition by competing with the 
natural substrate for the enzyme involved. Our first experiments were prompted 
by the finding of Becket (8, 9) that the first component of guinea pig comple- 
ment was an esterase  which  could be  inhibited by diisopropylfluophosphate 
(DFP), and by the knowledge that DFP could also prevent the anaphylactic 
release of histamine and slow  reacting substance  SRS-A  (10) from perfused 
guinea pig lung (11). We were also guided in our initial choice of inhibitors  by 
the finding of Cushman, Becker,  and Wirtz  (12) that immune hemolysis  is 
inhibited by thiols, esters  of arginine  and lysine, esters  or amides of tyrosine, 
and peptides with a terminal aromatic amino acid having a free carboxyl group. 
In a preliminary report (13) we noted that amino acid ester substrates and 
inhibitors of chymotrypsin prevent the anaphylactic release of histamine while 
substrates and inhibitors of trypsin do not. The present report extends these 
findings. It shows that acetylation of the ester substrate so as to introduce a 
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secondary pepfide bond enhances inhibitory capacity,  and that  the  relative 
effectiveness of the chymotrypsin substrates  in inhibiting anaphylaxis differs 
somewhat from their relative susceptibility to  hydrolysis  by  chymotrypsin. 
It demonstrates that substrates of carboxypeptidase and leucine aminopeptidase 
like those of trypsin are not inhibitory. It presents evidence that the phase of 
the anaphylactic reaction inhibited by DFP and other chymotrypsin  inhibitors 
is in a DFP-resistant precursor state until activated by the addition of antigen, 
while the phase of the reaction sensitive to the thiol inhibiting agent, N-ethyl- 
maleimide, is  available even prior  to  antigen addition.  As  a  result  of  these 
studies with inhibitors it has  been possible to  compare the  observed charac- 
teristics  of  antigen-induced histamine release  in guinea pig  lung with  those 
established for immune hemolysis (12, 14). 
Materials 
The esters, amides, and peptides were obtained mainly from Mann Research Laboratories, 
Inc., New York, while the amino acids and other compounds were obtained from several dif- 
ferent  sources, British  Drug Houses, Ltd., Dorset, England,  Hopkins and Williams, Ltd., 
Essex, England, and L. Light and Co., Ltd., Bucks, England. Bovine gamma globulin was 
supplied by Armour Corp., and albumin (egg) flake by British Drug Houses, Ltd.  Soybean 
trypsin inhibitor was obtained from Worthington Biochemical Corporation, Freehold, New 
Jersey. Diisopropylfluophosphate (DFP)  was obtained from Boots, Ltd.,  London; L-ly~ne 
ethyl ester was obtained from Dr. E. L. Becker; L-tyrosine ethyl ester, diacetyl T.-lysine  ethyl 
ester, and diacetyl L-lysine hydrazide were obtained from Dr.  R.  Pitt-Rivers  and Mr.  A. 
Brownstone; glycylglycylglycine  and L-leucylglycylglycine  were supplied by  Dr. F. Sanger; 
and three times recrystaUized egg albumin prepared by the method of Kekwick and Carman 
(15) was obtained from Dr. J. H. Humphrey. The ammonium salt of 5-hydroxyindoleacetic 
was obtained from Roche Products, Ltd., London, and was converted to the sodium salt by 
cation exchange chromatography. 
4-imidazole acetic acid was synthesized under the direction of Dr. J. W. Cornforth. 4-imi- 
dazole acetonitrile was prepared by the method of Dakin (16) and gave an uncorrected melting 
point of 136-138.5  ° which agrees satisfactorily with the value of 138  ° reported by Dakin (16). 
The nitrile was hydrolyzed to give 4-imidazole acetic acid. After crystallization from water, 
sublimation, and recrystallization the material melted with decomposition at 220-220.5  ° (un- 
corrected) which agrees satisfactorily with the reported corrected value of 222  ° (17). 
Methods 
Guinea pigs were sensitized by the injection of 10 per cent egg albumin or bovine gamma 
globulin in 0.5 per cent phenol, 1 ml. intraperitoneally and 1 ml. subcutaneously. Passively 
sensitized animals were obtained by the intrathoracic injection of serum containing 4 to 8 rag. 
of rabbit antiovalbumin. Approximately 3 weeks after injection of antigen for active sensitiza- 
tion or 48 hours after passive sensitization, the heart and lungs were excised. Visible blood 
was removed by immedate  perfusion through  the pulmonary  artery for  10 minutes with 
Tyrode's solution at 37°C. (10). The lung tissue was then chopped into rods 0.4 x 0.4 x 5.0 mm. 
with a McIlwaine chopper (18). The chopped tissue was washed with Tyrode's solution at 
23°C. and divided into 24 samples, each of approximately 100 mg. wet weight. These were 
incubated in Tyrode's solution at 37°C for 45 minutes with continuous agitation by rocking 
and then washed twice with Tyrode's solution at 37°C. Washing was carried out by removing 
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warm Tyrode's  solution. Immediately after the second wash each sample of tissue was immersed 
in 3.0 ml. warm Tyrode's with or without the potential inhibitor. Ten seconds  later the antigen, 
1.0 mg. ovalbumin or 3.0 rag. bovine gamma globulin per ml. reaction mixture, was added. 
After rocking for 15 minutes at 37°C., the supernatant fluid was removed from the tissue and 
kept at 0°C. until assayed on the same day using the isolated ileum of the guinea pig in the 
presence of 2 X  i0  -¢ •  atropine. Any potential inhibitor was always studied in four replicate 
tubes; three of the samples received antigen and the fourth served as a control for spontaneous 
release of histamine. The triplicate samples gave values which fell within 10 per cent of the 
mean. The pH of the Tyrode's solution containing the potential inhibitor was checked before 
each experiment and adjusted to pH 7.6-7.8 when necessary. In general, the anaphylactic re- 
lease of histamine in the control tubes containing  Tyrode's solution without inhibitor ranged 
from 3 to 8 pg. per gin. wet lung tissue and represented I0 to 30 per cent of the total tissue 
histamine. The total tissue histamine was estimated by biological assay of the solution ob- 
tained by complete extraction of chopped tissue to which antigen had not been added. The 
tissue was boiled in 5 ml. Tyrode's solution for 5 minutes and then the tube was placed in ice 
for I hour to allow complete diffusion. 
The standard dose of histamine acid phosphate used for the histamine assay on the isolated 
ileum ranged from 0.001 to 0.005/zg. per ml. calculated as base. The concentration of the in- 
hibitor in the supernatant did not in general interfere with the response of the guinea pig ileum 
to histamine at the dilution used for assay. In those instances when interference, enhance- 
ment, or inhibition, was present a correction was made by determining the effect of the poten- 
tial inhibitor on the standard histamine response. 
The experimental method differs in two ways from that used by Mongar and Schild in their 
studies with irLhibitors  of anaphylaxis (I) : perfnsed blood-free tissue was used in order to mini- 
mize any non-specific  contribution  from serum factors not adsorbed onto the tissue, and anti- 
gen was added ten seconds after the inhibitor so as to diminish any non-specific  effects due to 
prolonged contact between tissue and inhibitor prior to antigen addition. We reasoned that, if 
the inhibitor was acting exclusively  on an antigen-antibody  activated enzyme sequence,  there 
would be no advantage in adding the inhibitor 15 minutes before the antigen. 
RESULTS 
Time Course of the Anaphylactic Release of Histamine.--Fig.  1 shows the time 
course of histamine release after the addition of antigen, ovalbumin 1 mg. per 
mi. reaction mixture, to sensitized chopped guinea pig lung. Histamine began 
to appear  10 to  15  seconds after adding antigen, and two-thirds of the total 
amount to be released was in the supernatant fluid by the end of the 1st minute. 
The time course for the anaphylactic release of histamine from chopped tissue 
was virtually identical with that observed in perfused whole lung (10). Increas- 
ing the concentration of the antigen to 10 or even 50 rag. per mi. reaction mix- 
ture did not give greater histamine release than 1 rag. per ml. reaction mixture. 
Compounds Wkich Fail to Inhibit the Anapkylactic Release of ttistamine.--In 
Table I  are listed compounds which are not substrates of the common pepti- 
dases and which fail to inhibit the anaphylactic release of histamine at a  con- 
centration of  20 m~.  The levorotatory form of all amino acids  studied,  the 
racemic form of the aliphatic amino acids, esters of glutamic acid, glycine and 
glycylglycine, and a  variety of peptides,  polypeptides and acids all failed to 
inhibit the  anaphylactic release of histamine. 
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non-inhibitory. The first group are esters and amides or hydrazides of arginine 
and lysine, and are trypsin substrates (20). Neither the trypsin substrates nor 
the soybean trypsin inhibitor were inhibitory. The two substrates of leucine 
aminopeptidase tested (21), L-leucylglycylglycine  and L-leucineamide, were not 
inhibitory at a concentration of 5 rn~.  L-leucineamide appeared to show slight 
inhibition at 20 rn~, but the significance of this was difficult to interpret because 
at this concentration L-leucineamide released histamine in the absence of anti- 
gen. The third group are substrates of carboxypeptidase (20). When first tested 
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Fro. 1. Time course of histamine release after addition of antigen 
these compounds appeared to be inhibitory, but inhibition was also obtained 
with the related peptides carbobenzoxy-L-glutamic acid, carbobenzoxyglycine, 
and benzoylglycylglycine which were included as controls. In order to obtain 
solutions of these peptides they were dissolved in 0.2 N NaOH and neutralized 
with  1 N HC1 prior to bringing to volume with Tyrode's solution. Since this 
resulted in an appreciable increase in the NaC1 concentration of the reaction 
mixture,  the  effect of variation in  NaC1  concentration on  the  anaphylactic 
reaction was  investigated.  It was  observed that  the  anaphylactic release of 
histamine  from  chopped  guinea  pig  lung  was  extremely sensitive  to  small 
changes in the ionic strength of the suspending medium (22). When the experi- 
ments with the substrates of carboxypeptidase were repeated so that the ionic 
strength of the mixture containing the peptide was no greater than that of the 
controls, inhibition was no longer observed. TABLE I 
Compounds Which Fail to Inhibit the Anaphylactic Rdease of Histamine from Chopped, 
Sensitized Guinea Pig Lung* 
Amino acids  Esters  Peptides, polypeptides, and 
other compounds 
L-tryptophan 
~tyrosine~ 
L-phenylalanine 
~-arginine 
~-lysine 
L-leucine 
DL-leucine 
L-norvaline 
DL-norleucine 
~valine 
D~-alanine 
Glycine 
L-glutamic acid 
DL-aspartic  acid 
L-histidine 
~cysteine 
I,-serine 
L-glutamic ethyl ester 
Glycine ethyl ester 
Glycylglycine ethyl ester 
Glycylglycine 
Glycylglycylglycine§ 
nL-alanylglycine 
N-acetylglycine 
N-acetyl-L-lysine 
N-acetyl-DT.-leucine 
Glycyl-DL-leucine 
Carbobenzoxy-L-glutamic acid 
Carbobenzoxyglycine 
B enzoylglycylglycine 
Soybean trypsin inhibitorl] 
Acetic acid 
Propionic acid 
L-mandelic acid 
Phenylsucdnic acid 
4-imidazole acetic acid 
Sucrose 
Glucose 
*  Compounds producing  less  than 25  per  cent  inhibition  at  a concentration  of  20  mu were 
termed  non-inhibitory. 
Because  of  water insolubility  L-tyrosine  could  not  be  tested  at  greater  than 5  raM. 
§  Because  of  limited  supply  this  compound could  not be  tested  at greater  than 5 mu. 
I]  Test concentration  was 2.0  mg./ml. 
TABLE II 
Substrates Which Fail to Inhibit the Anaphylactic  Release of Histamine from Chopped, 
Sensitized Guinea Pig Lung* 
Trypsin substrates  Leucine aminopeptidase  substrates  Carboxypeptidase  substrates 
Benzoyl-L-arginine methyl ester 
Benzoyl-r-arginine amide 
r-lysine ethyl ester 
Diacetyl-L-lysine ethyl ester¶ 
Diacetyl-L-lysine hydrazide¶ 
bleucylglycylglycine  ~ 
L-leucine amide]] 
CBZ§ ol-glutamyl-~-tyrosine 
CBZ glycyl-L-phenylalanine 
CBZ glycyl-L-tryptophan 
B  enzoylglycyl-L-phenylala- 
nine 
* Compounds producing less than 25 per cent inhibition at a concentration of 20 mM were 
termed non-inhibitory. 
:~ Because of limited supply this compound could not be tested at greater than 5 raM. 
§ CBZ, caxbobenzoxy. 
[] Because L-leucine amide released histamine in the absence of antigen, observations at a 
concentration of greater than 5 mu were not considered reliable. 
¶ Because of limited supply these compounds could not be tested at greater than 10 mM. 
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Inhibition  of  the  Anaphylactic  Release  of Histamine  by  Chymotrypsin  Sub- 
strafes and Inhibitors.--The compounds which consistently produced more than 
50 per cent inhibition of the anaphylactic release of histamine are recorded in 
TABLE III 
The Inkibition of the Anapkylaaic Rdease of Histamine from Chopped, Sensitimt  Guinea Pig 
Lung by Chymotrypsin Substrates and Inhibitors 
Class of Inhibitor 
Chymotrypsin substrates 
Glycyl-L-tyrosine  amide 
L-leucine ethyl ester 
L-tyrosine ethyl ester 
N-acetyl-L-tyrosine  ethyl ester 
z-phenylalanine ethyl ester 
L-tryptophan ethyl ester 
N-acetyl-L-phenylalanine  ethyl ester 
N-acetyl-L-tryptophan  ethyl ester 
Bifunctional chymotrypsin inhibitors 
DL-phenylalanine 
D-phenylalanine 
DL-tryptophan 
D-tryptophan 
Acetyl-DL-phenylalanine 
Acetyl-I~z tryptophan 
Acetyl-L-tryptophan 
Glycyl-I~L-tryptophan 
Glycyl-~-tryptophan 
Benzoic acid 
5-hydroxyindoleacetic  acid 
Phenylacetie acid 
/3-Phenylpropionic acid 
/3-Indoleacetie acid 
/3-Phenylcinnamie acid (trans) 
/3-  (/3-Indole)propionie add 
Monofunctional chymotrypsin inhibitors 
Nicotinamide 
Phenol 
Skatole 
Indole 
Organophosphorus esterase inhibitor 
Diisopropylfluophosphat e 
Minimal concentration 
consistently  giving 
greater than 50 per 
cent inhibition 
20 
5 
5 
4 
3.5 
2 
1 
0.5 
20 
20 
20 
20 
20 
20 
20 
20 
20 
20 
20 
5 
2.5 
2.5 
2.5 
2.5 
5 
1 
1 
0.5 
Table III. The first group are esters of aromatic amino acids and are typical 
chymotrypsin substrates  (20).  The  observation that  the  esters are better in- 
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better substrates for chymotrypsin. The finding that the acetylated ester is in 
each instance a better inhibitor than the non-acetylated ester is also consistent, 
since introduction of a  secondary peptide bond makes the ester a  more sus- 
ceptible chymotrypsin substrate (20). On the other hand, the relative capacity 
of these esters to inhibit anaphylaxis is not the same as their relative suscepti- 
bility to pancreatic chymotrypsin. N-acetyl L-phenylalanine ethyl ester is a 
more potent inhibitor of the in vitro  anaphylacfic release of histamine than 
N-acetyl-L-tyrosine ethyl ester (Table III), but the latter is a  better chymo- 
trypsin substrate than the former (23).  Furthermore, L-leucine ethyl ester, a 
poor chymotrypsin substrate (20, 24), is as potent an inhibitor of anaphylaxis 
as L-tyrosine ethyl ester, which is a good substrate. 
These chymotrypsin substrates are termed trifunctional because they inter- 
act with chymotrypsin at three sites, the aromatic side chain, the secondary 
peptide bond or free amino group,  and the susceptible ester bond.  Whereas 
trifunctional compounds can  be  either  substrates  or  competitive inhibitors, 
compounds presenting the enzyme with only two such sites, namely an aromatic 
residue and a polar group separated from it, may bind even more firmly and are 
termed bifunctional inhibitors, while compounds containing only an aromatic 
residue can be monofunctional inhibitors (20).  It is noteworthy that 0.5  rnu 
of the substrate N-acetyl-L-tryptophan ethyl ester produced 50 per cent inhi- 
bition, whereas 20 mM of the bifunctional inhibitor, N-acetyl-L-tryptophan,  was 
required to achieve the same inhibition (Table III). The most active bifunc- 
tional inhibitors studied were 3-phenylpropionic acid, 3-phenylcinnamic acid 
(trans), 3-indoleacetic acid, and 3-(3-indole)propionic acid, and these produced 
more than 50  per cent inhibition of histamine release at a  concentration of 
2.5 raM. 
Because phenylacetic acid and 3-indoleacetic acid were inhibitory, 4-imida- 
zoleacetic and 5-hydroxyindoleacetic acid, degradation products of histamine 
(25)  and serotonin (26) respectively, were tested with the possibility in mind 
that they might provide a negative feedback mechanism which would make the 
anaphylactic reaction self-limiting. Introduction of a  hydroxyl group into the 
five position significantly reduced the inhibtory power of 3-indoleacetic acid 
(Table III), and 4-imldazole acetic acid had no inhibitory effect at all.  The 
failure of 4-imidazoleacetic acid to inhibit is probably due to the fact that the 
imidazole ring is basic while the indole and the phenyl rings are acidic and 
neutral respectively. L-mandelic acid, which differs from phenylacetic acid in 
that  the  acetic acid  side  chain  is  substituted  with  a  hydroxyl group,  and 
phenylsuccinic acid were also not inhibitory (Table I). 
The four monofunctional inhibitors (Table III) are noteworthy because the 
order of their relative effectiveness against in vitro anaphylaxis is the same as 
that observed by Huang and Niemann (27)  against chymotrypsin. With the 
exception of D-tryptophan ethyl ester, indole was the most potent competitive 
inhibitor of chymotrypsin listed by Green and Neurath (20), and it is also one 528  ANAPHYLAXIS  IN LUNG.  I 
of the two most potent inhibitors of anaphylaxis listed in Table III. The ability 
of phenol to inhibit the anaphylactic release of histamine was first described by 
Mongar and Schild (1), but the fact that phenol was a chymotrypsin inhibitor 
was not considered. 
Inhibition  of the  Anaphylactic  Release  o/ Histamine  by  DFP.--The  dose- 
response curve for the  organophosphorus esterase  inhibitor,  diisopropylfluo- 
phosphate (DFP), is depicted in Fig. 2. The concentration required to produce 
CONCENTRATION 
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0.25  x 
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FIo. 2. Dose response  curve for the inhibition of antigen induced histamine release by DFP 
(0  Q) and ~-tryptophan ethyl ester (TRYEe) (X  X). 
50 per cent inhibition was approximately 2 raM. Fig.  2 also shows  the dose- 
response curve for L-tryptophan ethyl ester. The unexpected finding that DFP, 
which is capable of inhibiting chymotrypsin on a 1:1 molar basis (28), required 
a  greater concentration to produce 50 per cent inhibition than certain of the 
substrates  and  monofunctional inhibitors  (Table  III)  can  be  attributed  to 
several factors. DFP can apparently react with  several different amino acid 
side groups, including hydroxyl, amino,  and sulfhydryl groups  (29).  Jansen, 
Fellows Nutting, and Balls (30)  found that the concentration of DFP needed 
to  inhibit  citrus  acetylesterase could be  reduced to  one-tenth  after  further 
purification of the enzyme, whereas a fifty times increase in the concentration 
of DFP was needed when inhibition was attempted in the presence of substrate. K.  F.  AUSTEN  AND  W.  E.  BROCKLE~tu~ST  529 
Similarly, when Becker (8) attempted to inhibit immune hemolysis in the pres- 
ence of diluted whole complement 2.5 to 8.3 rn~ of DFP was required, but when 
DFP was used to inhibit the esterase activity of the first component of comple- 
ment (C'I) on the washed red cell only 0.083 mM DFP was needed. Thus, the 
finding that 2 n~ of DFP was needed to produce 50 per cent inhibition of the 
anaphylacfic release of histamine from chopped lung can probably be attributed 
to the following: the binding of DFP at tissue sites not participating in the 
reaction; the very short time which  DFP has  to combine with the antigen- 
antibody activated enzyme; and the fact that DFP must do this in the presence 
of natural substrate. 
TABLE IV 
The Effect of Adding Inhibitor and Then Washing It Out before the Addition of 
Antigen to the Sensitized Tissue 
Inhibitor 
A 
DFP 
L-phenylalanine ethyl ester 
Phenylacetic acid 
Indole 
B 
N-ethylmaleimide 
Concentra- 
tion 
10 
20 
20 
2 
Histamine release in ~,g./gm wet 
lung tissue 
Inhibitor  Inhibitor 
present  washed out* 
0.27  5.1 
0.6  3.5 
0.54  2.4 
0.27  3.0 
3.7  0.48 
ControH: 
6.0 
4.1 
2.7 
2.7 
9.6 
* Tissue was washed four times in Tyrode's solution to remove the inhibitor before  antigen 
was added. 
Tyrode's solution only. 
Evidence  That the Inhibitors  Are Acting Exclusively on an Antigen-Antibody 
Activated Step.--Since DFP inhibits esterases irreversibly, it was used to ascer- 
tain whether the DFP-inhibited enzyme essential to anaphylaxis in guinea pig 
lung was present before or only subsequent to antigen addition. Sensitized tissue 
was incubated with  10 m~ DFP for 15 minutes and then washed four times 
with Tyrode's solution before the addition of antigen. On the addition of anti- 
gen this tissue gave virtually the same histamine release as control tissue treated 
in a  similar fashion with Tyrode's solution only (Table IVA). Since DFP in- 
hibited the antigen-induced release of histamine only when present at the time 
of antigen addition, DFP must be acting exclusively on an antigen-antibody- 
activated enzyme which exists in lung tissue in a  precursor form resistant to 
DFP until activated by the antigen-antibody interaction. 
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hibitors used in this work destroyed or released antibody or otherwise impaired 
the ability of the sensitized tissue to respond to antigen,  the sensitized tissue 
was incubated  with  20  rn~  L-phenylalanine ethyl ester,  20  ii~  phenylacetic 
acid, or 2 m~ indole for 15 minutes and then washed four times with Tyrode's 
solution  to  remove the inhibitor  before adding  antigen.  As  shown  in  Table 
IVA, on the addition of antigen these tissues gave virtually the same histamine 
release  as  control  tissue  treated  in  a  similar  fashion  with  normal  Tyrode's 
solution. In each of these experiments the quantity of inhibitor used was suffi- 
cient to give more than 80 per cent inhibition of the antigen-induced histamine 
TABLE V 
Th* Effect of InhiMtors  on th* A naphylactic Rdease of Histamine in Passively 
Sensitized  Guinea Pig Tissue* 
Inhibitor 
N-acetyl-L-phenylalanine  ethyl ester 
L-tryptophan ethyl ester 
Indole 
Phenylacetic acid§ 
Concentra- 
tion 
mM 
1 
2.5 
1 
5 
Histamine release in 
ttg./gm, wet lung tissue 
Inhibitor  Control$ 
present 
2.4  4.1 
1.9  4.1 
1.1  4.1 
1.4  2.7 
Inhibition of 
histamine 
release 
per cost 
41 
54 
73 
48 
* Guinea pigs sensitized with  4 to 8 rag. of rabbit antiovalbumin, and histamine release 
initiated by three times recrystallized ovalbumin, 1 me. per ml. reaction mixture. 
Tyrode's solution only. 
§ Data taken from another experiment. 
release. This indicates that these inhibitors are probably acting on a  reaction 
activated by the addition of antigen.  Furthermore, when the tissues in which 
the antigen-induced histamine release had been prevented by the presence of 
inhibitor were washed and treated a  second time with antigen,  there was no 
histamine release. This desensitization demonstrates that the inhibitor has not 
prevented effective antigen-antibody interaction. 
Since the experiments on which Tables I  to IV are based involve the ana- 
phylactic release of histamine from tissue of animals sensitized with crude oval- 
bum_in, it  seemed important to repeat some of these observations using pas- 
sively  sensitized  tissue  and  tissue  from  animals  actively  sensitized  with  a 
different antigen. Some of the studies in which three times recrystaUized oval- 
bumin was used to initiate histamine release from animals passively sensitized 
with  rabbit  antiovalbumin  are  noted  in  Table V.  The  concentration  of the 
esters and of phenylacetic acid was selected so as to give 50 per cent inhibition 
and the concentration of indole used was expected to give about 70 per cent K.  ~.  AUSTEN  AND  W.  E.  BROCKLEIiuRST  531 
inhibition.  The inhibition achieved compares favourably with that anticipated 
from the studies with actively sensitized tissue. 
To obtain comparative data with two different antigen-antibody systems in 
the same  tissue,  animals were  simultaneously actively sensitized  with both 
ovalbumin and bovine gamma globulin. As shown in Table VI, the addition 
of ovalbumin to the chopped tissue released 6.7 #g. of histamine per gin. of wet 
luvg tissue and the addition of bovine gamma globulin to a different sample of 
the same lung tissue  released  4.2  #g.  histamine per gin. of wet lung tissue. 
L-tryptophan ethyl ester in a concentration of 2.5 mM inhibited the ovalbumin- 
TABLE VI 
The Inhibition of the Anapkylactic Rdea~e of Histamine in Doubly Sensitized 
Guinea Pig Tissue* 
Antigen  used for anaphylaxis~ 
Ovalbumin 
Bovine gamma globulin 
Ovalbumin and bovine gamma globulin 
Histamine release in ~g./gm. 
wet lung tissue 
~-tryptophan 
ethyl ester  Control§ 
(2.s rex) 
1.7  6.7 
1.1  4.2 
2.1  6.6 
Inhibition of 
histamine 
release 
p~r ¢$r,J 
75 
74 
68 
*  Animals sensitized  by simultaneous injection  of  ovalbumin and bovine  gamma globulin. 
Ovalbumin used  in  a concentration  of  I  rag.  per  ml.  reaction  mixture  and bovine gamma 
globulin  in  a concentration of  3 rag.  per  ml. reaction  mixture. 
§  Tyrode's  solution  only. 
induced histamine release 75 per cent and the bovine gamma globulin-induced 
histamine release 74 per cent. Thus, the inhibitor was equally effective against 
both antigen-antibody systems. It is of interest that virtually the same inhibi- 
tion was achieved with the ester whether the two antigens were added simul- 
taneously or individually. 
The Effect of Thiols and Thiol Alkylating or Oxidizing Agents on the Anapkylac- 
tic Release of ttistamine.--In view of the evidence that the intracellular pepti- 
dase,  eathepsin  C,  splits  dipeptides  such  as  glycyl L-tyrosinamide  and  is 
inhibited by chymotrypsin substrates such as L-phenylalanine ethyl ester and 
L-tyrosinamide  (31, 32), the possible participation of eathepsin C in the ana- 
phylactic release of histamine was further investigated. Since cathepsin C is 
activated by thiols such as reduced glutathione, thioglyeollic acid, and cysteine 
and inhibited by the  thiol alkylating agent,  iodoacetate (32), the effect of 
thiols and thiol alkylating or oxidizing agents on the anaphylactic reaction was 
determined. The thiols noted in Table VII released no histamine by themselves 
and neither enhanced nor inhibited the anaphylactic release of histamine.  In 532  ANAPHYLAXIS IN  LUNG.  I 
contrast,  as shown in Table VII, agents which attack thiol  groups inhibited 
histamine release. 
When tissue is incubated with 1 m~ of N-ethylmaleimide for 15 minutes and 
then washed four times to remove the inhibitor before adding antigen, there is 
marked inhibition  (Table IVB). In fact, despite the washing,  the  15  minute 
contact between the inhibitor and the tissue prior to washing  and adding anti- 
gen produced more inhibition than when the antigen was added in the presence 
of the inhibitor. Thus, in contrast to the situation with the chymotrypsin sub- 
TABLE  VII 
The Effect of Thiol Compounds and Thiol Inhibitors on the Anaphylaaic Rdease of 
Histamine from Guinea Pig Lung 
Minimal concentration  giving 
Class of inhibitor  greater than 50 per cent 
inhibition 
mM 
Thiols 
Cysteine 
ThioglycoUic  acid 
~/-Glutamylcysteinylglycine  (reduced ghitathione) 
Thai inhibitors 
3,-glutamylcystinylglycine (oxidized glutathione) 
T-Glutamylcystinylva]ine 
Iodoacetate 
N-ethy|maleimide 
Not inhibitory* 
Not inhibitory 
Not inhibitory 
10 
5 
2 
1 
* Compounds producing less than 25 per cent inhibition at a concentration of 20 mM were 
considered not inhibitory. 
strates and inhibitors,  including  DFP, the phase of the in vitro anaphylactic 
reaction sensitive to the thiol inhibitor is available in the absence of antigen. 
DISCUSSION 
The observation  that  the anaphylactic release  of histamine  from chopped 
guinea pig lung is prevented by chymotrypsin substrates and inhibitors (Table 
III),  but not by trypsin,  carboxypeptidase,  or leucine  aminopeptidase  sub- 
strates (Table II) implies  that activation of a  chymotrypsin-like enzyme is a 
necessary condition for this reaction. The ability of chymotrypsin substrates to 
inhibit  the  anaphylactic  release  of histamine  is  not  limited  to  tissue  from 
animals actively sensitized  with ovalbumin, but can also be demonstrated with 
tissue from animals passively sensitized  with rabbit antiovalbumin (Table V) 
or actively sensitized  with  bovine gamma  globulin  (Table  VI).  Since  DFP 
inhibited the anaphylactic release  of histamine only when present at the time 
of antigen addition (Table IVA), the DFP-sensitive enzyme must exist in lung K.  1  e.  AUSTEBI  AND  W.  E.  BROCKLEI~UI(ST  533 
tissue in a DFP-resistant precursor form until activated by the antigen-anti- 
body interaction. This would be consistent with the fact that chymotrypsinogen 
and  trypsinogen  are resistant  to DFP,  while  chymotrypsin and  trypsin are 
inhibited (28). That DFP, the other chymotrypsin inhibitors, and the chymo- 
trypsin substrates are acting on an antigen-antibody activated step is indicated 
by the failure of any of these substances to inhibit if removed from the tissue 
by washing prior to antigen addition (Table IVA), and by the complete desensi- 
tization of the tissue without histamine  release  when the antigen is added in 
the presence of the inhibitor. 
Acetylation of the ester substrate,  so as to introduce a  secondary peptide 
bond, enhances effectiveness both as an inhibitor of in vitro anaphylaxis (Table 
III) and as a substrate of chymotrypsin (20). However, the relative potency of 
these acetylated and  non-acetylated aromatic  esters as inhibitors  of in  vitro 
anaphylaxis (Table III) differs from their relative susceptibility to pancreatic 
chymotrypsin (23).  Furthermore,  leucine ethyl ester inhibits antigen-induced 
histamine  release  (Table III),  although  it is a  very poor chymotrypsin sub- 
strate (20, 24) in comparison to the aromatic amino acid esters. This inhibitory 
activity of L-leucine ethyl ester cannot be used as evidence for the participation 
of leucine aminopeptidase in the anaphylactic reaction because L-leucine ethyl 
ester is neither a substrate nor an inhibitor of leucine aminopeptidase (21, 33). 
The relative ability of substrates to act as inhibitors of an enzyme does not 
necessarily parallel  their  susceptibility as  substrates,  and  so the  studies on 
inhibition  of  in  vitro  anaphylaxis  are  only  presumptive  evidence  that  the 
chymotrypsin-like  enzyme  required  for  histamine  release  differs  from  pan- 
creatic chymotrypsin in substrate specificity.  The fact that pancreatic chymo- 
trypsin failed to release  histamine  from chopped guinea  pig lung  (13)  may 
mean that these possible differences  in substrate specificity are significant,  or 
may simply mean that extracellular chymotrypsin of pancreatic origin  is not 
an adequate substitute for the antigen-antibody-activated chymotrypsin-like 
enzyme which presumably is activated near its natural substmte. 
The finding that N-ethylmaleimide inhibited the anaphylactic reaction even 
when the tissue was washed repeatedly prior to antigen addition,  shows that 
N-ethylmaleimide is not necessarily acting on an antigen-antibody-activated 
step. Either that part of the anaphylactic reaction sensitive to N-ethylmalemide 
is susceptible to inactivation prior to the antigen-antibody interaction, or the 
thiol inhibiting agent is preventing histamine release in some non-specific way. 
In either case the situation with the thiol inhibitor is in striking contrast to 
that with DFP which is not inhibitory unless present at the time of antigen 
addition and is clearly acting on an antigen-antibody activated step. 
All the conclusions in the present report are based on the release of histamine 
as an index of the in vitro  anaphylactic reaction, but some observations have 
also been made on the effect of these inhibitors on the other known product of 534  ANAPHYLAXIS IN  LUNG.  I 
anaphylaxis in guinea pig tissue,  slow  reacting substance SRS-A  (10).  DFP 
inhibits the anaphylactic release of both histamine and SRS-A from perfused 
guinea pig lung (11),  and L-tryptophan ethyl ester inhibits the anaphylactic 
release of both histamine and SRS-A from chopped guinea pig lung (34).  In 
both instances the inhibition of histamine and SRS-A release are similar in 
degree, indicating that activation of the chymotrypsin-like enzyme is a neces- 
sary step in the release of both these pharmacologically active agents. 
The steps leading to the anaphylactic release of histamine and SRS-A from 
guinea pig tissue are presumably multiple and there is no reason to assume 
that the characteristics of this reaction are properties of a  single enzyme. In 
fact,  despite  the  initial  perfusion  and  subsequent  washing  of  the  chopped 
tissue, it is still possible that adsorbed serum factors are present and perhaps 
even necessary for the in vitro anaphylactic reaction. In view of the probable 
complexity of this reaction it would be unreasonable to expect an exact parallel 
with other biological systems to which it may nevertheless be related. Attention 
will, however, be drawn to the similarities and differences which emerge from a 
comparison of the anaphylactic reaction with immune hemolysis. In addition, 
the relevance of certain intraceUular enzymes will be considered. 
The mast cell enzymes are of interest because much of the tissue histamine is 
located in mast cells (35),  and because the mast cells in the mesentery of the 
sensitized guinea pig (5) or rat (6) are degranulated on the addition of antigen. 
Benditt and Arase (36)  observed that suspensions of isolated intact rat mast 
cells exhibit chymotrypsin-like activity which is inhibited by DFP. Although 
such mast cell activity could be the source of the chymotrypsin-like enzyme 
implicated in the anaphylactic release of histamine from guinea pig lung, there 
is one important discrepancy. The rat mast cell activity was demonstrated in 
non-sensitized animals without prior activation by an antigen-antibody reac- 
tion. Hence, unless the rat mast cell enzyme was activated during isolation or 
assay, it follows that the rat mast cells do not contain the inactive precursor 
form which seems to exist in guinea pig lung. 
The  intracellnlar  enzyme, cathepsin  C,  like  the  anaphylactic reaction  in 
guinea pig lung, is inhibited by chymotrypsin substrates (31) and by iodoace- 
tate (32). However, cathepsin C is resistant to 1 m~ DFP and is activated by 
thiols (32), whereas the anaphylactic reaction is inhibited by DFP (Table III) 
and is not affected by the thiols (Table VII). Potassium cyanide also activates 
cathepsin C (32),  but inhibits the anaphylactic release of histamine in guinea 
pig lung (1, 37).  Thus, cathepsin C  can not be involved in the anaphylactic 
release of histamine unless these discrepancies are attributed to other partici- 
pating factors which have not yet been characterized. 
Since bifunctional chymotrypsin inhibitors are effective inhibitors of carboxy- 
peptidase (20, 38),  enzymes of the latter group might also be implicated in in 
vitro  anaphylaxis  in  guinea  pig.  The  fact  that  carboxypeptidase  is  DFP- K.  ~'.  AIYSTEN  AND  W.  ~E.  BROCKLEHURST  535 
resistant does not exclude it from consideration in a multiple step system. On 
the other hand, the failure of substrates of carboxypeptidase to inhibit (Table 
II) suggests  that such activity may not be involved. The finding that mono- 
basic fatty acids inhibit anaphylaxis (34) could also be used as evidence for the 
participation of a carboxypeptidase-like enzyme, but carboxypeptidase is most 
effectively inhibited by short chain fatty acids like valeric (38), while the in 
vitro anaphylactic reaction is poorly inhibited by valeric in comparison to the 
effect of the longer fatty acids like decanoic or dodecanoic (34). 
A comparison of hemolysis of the sensitized  red cell by guinea pig comple- 
ment with the anaphylactic release of histamine from guinea pig lung is of 
interest, because complement has been implicated in the in vitro anaphylactic 
release of histamine from rabbit platelets (39) and in the production of passive 
cutaneous anaphylaxis in the rat (40). DFP, an inhibitor of the first component 
of complement (C'I)  (8),  and N-acetyl-L-tyrosine ethyl ester, a  substrate of 
Cq (.9), inhibit both immune hemolysis (8, 12) and the anaphylactic release of 
histamine (Table III) from guinea pig lung. The heat-labile, calcium-requiring 
factor necessary for the in vitro anaphylactic reaction (2, 3) could also be cited 
as evidence for the participation of CPl, although the anaphylactic mechanism 
is heat-labile at 45°C. while Cq is labile at 56°C. Evidence to involve the third 
component of complement (C~3) is also available.  The sensitivity of the ana- 
phylacfic release of histamine from chopped guinea pig lung to changes in the 
salt concentration of Tyrode's solution (22) is remarkably similar to the effect 
of variation in salt concentration on lysis of the sensitized red cell--carrying 
the first, fourth, and second components of complement (EACq,4,2)--by the 
addition of C~3 (41). Furthermore, this reaction between the EACq ,4,2 cell 
and CP3 is inhibited by salicylaldoxime  (42), and so is the anaphylactic release 
of histamine (22); 0.5 rn~r salicylaldoxime causing 50 per cent inhibition in each 
case. Although magnesium is required for immune hemolysis (14), but not for 
the in vitro anaphylactic reaction in guinea pig lung (3), it is possible to dis- 
count this difference by assuming that the tissue supplies the small amount of 
magnesium necessary, when none is  present in  the suspending  medium. In 
experiments in which anaphylaxis has been prevented by chelation of calcium 
and magnesium (3,  43)  with ethylenediaminetetraacetate, the restoration of 
the anaphylactic reaction by the addition of calcium cannot be attributed 
solely  to  a  calcium  requirement, because  Ca  ++  displaces  Mg++  from  the 
chelating agent. 
There are, at least, six differences between in vitro anaphylaxis in guinea pig 
lung and immune hemolysis. (a) Thiols such as cysteine, thioglyeollic acid, and 
reduced glutathione inhibit immune hemolysis (12) and the esterase activity of 
the first component of complement (44), but do not inhibit anaphylaxis (Table 
VII). (b) Iodoacetate does not inhibit immune hemolysis (45), but iodoaeetate 
and several thiol oxidizing agents produce irreversible  changes which prevent 536  ANAPHYLAXIS IN  LUNG.  I 
anaphylaxis (Table IVB, Table VII).  (c) Esters of basic amino acids such as 
arginine  and lysine inhibit  immune hemolysis (12),  but do not inhibit  ana- 
phylaxis (Table II). (d) Peptides with a terminal aromatic amino acid exhibiting 
a free carboxyl group, i.e. carboxypeptidase substrates, inhibit immune hemoly- 
sis (12), but do not prevent anaphylaxis (Table II). (e) Potassium cyanide does 
not prevent immune hemolysis (45), but does inhibit the anaphylactic release 
of histamine  (1, 37).  (f) Phenylacetic acid does not inhibit immune hemolysis 
at a concentration of 20 m~ (12), but 5 m~ is sufficient to produce 50 per cent 
inhibition of antigen-induced histamine release (Table III). 
Despite these differences  it can still  be reasoned that  complement partici- 
pates merely at one stage in the in dtro  anaphylactic reaction, and that  the 
remaining  steps differ in the two phenomena and are responsible  for the dis- 
crepancies  between immune hemolysis and antigen-induced histamine release. 
The final  decision  as to whether or not complement is involved must await 
further progress in the understanding of the in vitro anaphylactic reaction and 
its dissection into individual steps as is being done with immune hemolysis (14). 
If this can be accomplished,  a  detailed comparison including  studies with in- 
hibitors and substitution of the complement components into the anaphylactic 
sequence will reveal whether or not complement is required for anaphylaxis in 
guinea pig lung. 
SUMMARY 
The quantitative release of histamine  by specific  antigen from pcrfuscd, 
chopped, sensitized  guinea pig lung has been used to study the effect  of pepti- 
dase substrates  and inhibitors  on the anaphylactic reaction. 
The anaphylactic release of histamine is prevented by chymotrypsin  sub- 
stratcs  and inhibitors  but not by trypsin,  carboxypeptidasc, or leucine  amino- 
peptidasc  substrates or the soybean  trypsin inhibitor. The  chymotrypsin 
substrates  and inhibitors  appear to be acting on an antigen-antibody-activated 
step because these substances fail  to inhibit  if  the tissue  is washed free  of them 
prior to antigen addition,  and because there is complete desensitization  of the 
tissue  without histamine release  when the antigen is added in the presence of 
these inhibitors. The inhibitors work equally well in tissue from passively 
sensitized animals  or in tissue from animals  actively sensitized with either 
ovalbumin or bovine gamma globulin.  These observations suggest that activa- 
tion  of a chymotrypsin-likc enzyme is a necessary condition for the anaphylac- 
tic  release  of histamine in guinea pig lung. 
Diisopropylfluophosphatc is inhibitory  when present at the time of antigen 
addition but not when the tissue  is  washed free  of unfixed diisopropyl~uophos- 
phatc prior to adding antigen. This indicates that diisopropylfluophosphate 
must be acting exclusively  on an enzyme which exists  in lung tissue  in a pre- 
cursor form resistant  to diisopropylfluophosphate until  activated by the anti- 
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Thiol alkylating or oxidizing agents also prevent the anaphylactic release of 
histamine, but in contrast to the situation with diisopropylfluophosphate and 
the  other  chymotrypsin  inhibitors,  the  phase  of  the  anaphylactic  reaction 
inhibited  by  N-ethylmaleimide  is  available  prior  to  the  antigen-antibody 
interaction. 
The similarities and differences between immune hemolysis and anaphylaxis 
in chopped guinea pig lung are considered in detail. 
The invaluable technical assistance of Mr. Brian McMahon is gratefully acknowledged. 
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